Annette Campbell-White is an accomplished executive venture capitalist with a proven track record of leadership as a founding or lead investor into successful companies that have created groundbreaking biomedical technologies.

Widely recognized as a pioneer for women in venture capital investment, Annette was the first biotechnology analyst on Wall Street and the first female partner at Hambrecht & Quist, a leading international investment banking firm. From 1986 until her retirement in 2015, Annette was Founder and Senior Managing Partner of MedVenture Associates, a biomedical venture capital firm. There, Annette initiated MedVenture investments in emerging biomedical technologies, such as companies that produced the first off-fingerstick glucose blood-testing monitor, the first cervical disk implant, and the first digital hearing aid.

A strong supporter of the arts, Annette has served on the boards of several performing arts associations, including the San Francisco Opera and Cal Performances. In 1997, she established the Kia Ora Foundation, (www.kiaora.org), whose scholarships for post-graduate music students from New Zealand enable study abroad. Her memoir, Beyond Market Value; A Memoir of Book Collecting and the World of Venture Capital, was published in 2019.